Global Human Growth Hormone Market

Global Human Growth Hormone Market Size, Trends & Analysis - Forecasts to 2026 By Application (Growth Hormone Deficiency [Adult Growth Hormone Deficiency and Pediatric Growth Hormone Deficiency] and Turner Syndrome [Idiopathic Short Stature, Prader-Willi Syndrome, Small for Gestational Age, and Others]), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, and Specialty Pharmacy), Competitive Landscape, Company Market Share Analysis, and Competitor Analysis

Category Healthcare

Format

This report was recently updated on April 13 2024 with the latest and most recent market numbers

Human Growth Hormone Market Insights

Human growth hormone (HGH) is often regarded as Somatotropin. It is a version of a peptide hormone that stimulates development, cell replication, and cellular reconstruction. Consequently, it’s a valuable aspect of the human growth phase. The pituitary gland is primarily accountable for generating human growth hormones. This gland is located under the brain at the foundation of the skull. It promotes human development while still increasing lean muscles. Moreover, human growth hormone, which is synthesized, is used in a variety of medications, dietary additives, and various goods.

Human growth hormones are extensively being used to treat chronic kidney disease, children born with low birth weight, Prader-Willi syndrome, Turner syndrome, human growth hormone deficiency secondary to pituitary tumors, or related treatment, and muscle wasting disease. These are often utilized to maximize workout capability, bone mass, lean mass, and fat levels. The rising occurrence of severe chronic diseases, as well as an elderly demographic, are driving the overall human growth hormone market forward. The market for human growth hormones will increase as medical research advances and hormone therapy becomes more common. Through the forecast period, such factors would boost human growth hormone demand.

The factors driving the human growth hormone market are increasing demand for growth hormones to enhance the physical look & facial pattern among younger as well as older generations and rising cases of growth deficiency among children, thereby resulting in increased use of growth hormones. Moreover, proliferating awareness and knowledge regarding the usage of GH in the treatment of numerous growth hormones or other hormonal imbalance conditions is the key market driver. Also, the increasing number of companies bringing in new and cost-effective products will further help in generating skyrocketing demand in the global human growth hormone market.

Because of developing cases of neurodegenerative diseases, pituitary tumors, skeletal defects, cardiac, neural, and metabolic anomalies, the overall human growth hormone market is widening at a significant rate. The aforementioned conditions can be effectively cured with human growth hormone, which increases its demand and, as a result, the market's growth.

Nevertheless, the unfavorable effects of artificial growth hormones, including muscle pain, knee pain, and fluid accumulation, as well as the exorbitant prices of medications utilizing these growth hormones, are impeding the development of the human growth hormones market. Furthermore, in the coming years, the human growth hormone market is expected to be disrupted by strict government regulations.

Besides that, several firms are participating in research and development to create a growth hormone with less adverse effects, and it would be a long-acting hormonal treatment. Furthermore, the rapid production of innovative transgenic human growth hormones is projected to boost the human growth hormone market throughout the forecast period. Moreover, insurance plans that assist patients with obtaining medical treatments at reasonable costs are on the increase. Governments in a multitude of established and emerging countries are also taking steps to encourage such health care plans. The increasing proportion of such government policies would also help drive global demand.

global human growth hormone market

Human Growth Hormone: By Application

Based on application, the human growth hormone market can be segregated into growth hormone deficiency and turner syndrome. Growth hormone deficiency is further classified as adult growth hormone deficiency and pediatric growth hormone deficiency. While Turner syndrome is further classified as idiopathic short stature, Prader-Willi syndrome, small for gestational age, and others. The growth hormone deficiency segment held the largest share as the application segment is concerned, with the turner syndrome segment being the fastest-growing segment. The rising birth rates per year, as well as an increase in the reported cases of multiple disorders among children, are hastening the market's expansion. Furthermore, rising public concern about early phase treatment and subsequent medical care drives consumer demand.

Human Growth Hormone: By Distribution Channel

Human growth hormone is classified into four distribution channels: hospital pharmacy, retail pharmacy, online pharmacy, and specialty pharmacy. The hospital pharmacy segment has the highest share as per distribution channel is concerned owing to the larger number of people visiting hospitals for treatment. This high proportion is correlated to an increase in hospital admissions as a result of increased human understanding of GH disorder and care options. Furthermore, rising hospital improvement activities with cutting-edge infrastructure and treatment facilities are boosting growth in this market segment.

asia pacific human growth hormone market

Human Growth Hormone Market: By Region

As per the geographical analysis, the market of Human Growth Hormone can be classified into North America (the US, Canada, and Mexico), Asia Pacific (India, China, Japan, Malaysia, Singapore, and Rest of Asia Pacific), Europe (Germany, United Kingdom, Italy, France, Spain, Netherlands, and Rest of Europe), Middle East & Africa and Central South America. North America is dominating this market owing to its increasing proportion of available growth treatment procedures for the core demographics and the rising number of companies dealing with growth hormone products. Furthermore, the growing initiatives in hormonal condition treatments accompanied by numerous research & development projects, the substantial participation of major competitors, and the medical investment in this domain are all contributing to regional market growth. The European human growth hormone market is extremely fragmented as a result of increased acquisitions and mergers within all the region's big players. The Asia Pacific is leading in terms of CAGR due to the rising number of growth deficiencies among core demographics. Moreover, major companies are focusing on acquiring a significant market share in developing economies of the Asia Pacific such as Japan and China by substantially involved in the production of innovative drugs and their approval by the FDA.

Human Growth Hormone Market Share and Competitor Analysis

Novo Nordisk A/S, Pfizer, Inc, Eli Lilly and Company, Sandoz International GmbH (Novartis AG), Merck KGaA, Genentech, Inc (Roche), Ferring Pharmaceuticals, Teva Pharmaceutical Industries, Ltd, and Ipsen among others, are the top players in the human growth hormone market.

Please note: This is not an exhaustive list of companies profiled in the report.

Chapter 1 Methodology

1.1 Market Scope & Definitions

1.2 Estimates & Forecast Calculation

1.3 Historical Data Overview And Validation

1.4 Data Sources

1.4.1 Secondary

1.4.2 Primary

Chapter 2 Report Outlook

2.1 Human Growth Hormone Market Overview, 2019-2026

2.1.1 Industry Overview

2.1.2 Application Overview

2.1.3 Distribution Channel Overview

2.1.4 Regional Overview

Chapter 3 Human Growth Hormone Market Trends

3.1 Market Segmentation

3.2 Industry Background, 2019-2026

3.3 Market Key Trends

3.3.1 Positive Trends

3.3.1.1 Rising cases of growth deficiency among core demographics

3.3.1.2 Increasing number of companies bringing in new and
cost-effective products

3.3.2 Industry Challenges

3.3.2.1 Side effects of these hormones

3.4 Prospective Growth Scenario

3.4.1 Application Growth Scenario

3.4.2 Distribution Channel Growth Scenario

3.5 COVID-19 Influence over Industry Growth

3.6 Porter’s Analysis

3.7 PESTEL Analysis

3.8 Value Chain & Supply Chain Analysis

3.9 Regulatory Framework

3.9.1 North America

3.9.2 Europe

3.9.3 APAC

3.9.4 LATAM

3.9.5 MEA

3.10 Technology Overview

3.11 Market Share Analysis, 2020

3.11.1 Company Positioning Overview, 2020

Chapter 4 Human Growth Hormone Market, By Application

4.1 Application Outlook

4.2 Growth Hormone Deficiency

4.2.1 Market Size, By Region, 2019-2026 (USD Million)

4.2.2 Market Size, By Adult Growth Hormone Deficiency, 2019-2026 (USD Million)

4.2.3 Market Size, By Pediatric Growth Hormone Deficiency, 2019-2026 (USD Million)

4.3 Turner Syndrome

4.3.1 Market Size, By Region, 2019-2026 (USD Million)

4.3.2 Market Size, By Idiopathic Short Stature, 2019-2026 (USD Million)

4.3.3 Market Size, By Prader-Willi Syndrome, 2019-2026 (USD Million)

4.3.4 Market Size, By Small for Gestational Age, 2019-2026 (USD Million)

4.3.5 Market Size, By Others, 2019-2026 (USD Million)

Chapter 5 Human Growth Hormone Market, By Distribution Channel

5.1 Distribution Channel Outlook

5.2 Hospital Pharmacy

5.2.1 Market Size, By Region, 2019-2026 (USD Million)

5.3 Retail Pharmacy

5.3.1 Market Size, By Region, 2019-2026 (USD Million)

5.4 Online Pharmacy

5.4.1 Market Size, By Region, 2019-2026 (USD Million)

5.5 Specialty Pharmacy

5.4.1 Market Size, By Region, 2019-2026 (USD Million)

Chapter 6 Human Growth Hormone Market, By Region

6.1 Regional outlook

6.2 North America

6.2.1 Market Size, By Country 2019-2026 (USD Million)

6.2.2 Market Size, By Application, 2019-2026 (USD Million)

6.2.3 Market Size, By Distribution Channel, 2019-2026 (USD Million)

6.2.4 U.S.

6.2.4.1 Market Size, By Application, 2019-2026 (USD Million)

6.2.4.2 Market Size, By Distribution Channel, 2019-2026 (USD Million)

6.2.5 Canada

6.2.5.1 Market Size, By Application, 2019-2026 (USD Million)

6.2.5.2 Market Size, By Distribution Channel, 2019-2026 (USD Million)

6.3 Europe

6.3.1 Market Size, By Country 2019-2026 (USD Million)

6.3.2 Market Size, By Application, 2019-2026 (USD Million)

6.3.3 Market Size, By Distribution Channel, 2019-2026 (USD Million)

6.3.4 Germany

6.3.4.1 Market Size, By Application, 2019-2026 (USD Million)

6.3.4.2 Market Size, By Distribution Channel, 2019-2026 (USD Million)

6.3.5 UK

6.3.5.1 Market Size, By Application, 2019-2026 (USD Million)

6.3.5.2 Market Size, By Distribution Channel, 2019-2026 (USD Million)

6.3.6 France

6.3.6.1 Market Size, By Application, 2019-2026 (USD Million)

6.3.6.2 Market Size, By Distribution Channel, 2019-2026 (USD Million)

6.3.7 Italy

6.3.7.1 Market Size, By Application, 2019-2026 (USD Million)

6.3.7.2 Market Size, By Distribution Channel, 2019-2026 (USD Million)

6.3.8 Spain

6.3.8.1 Market Size, By Application, 2019-2026 (USD Million)

6.3.8.2 Market Size, By Distribution Channel, 2019-2026 (USD Million)

6.3.9 Russia

6.3.9.1 Market Size, By Application, 2019-2026 (USD Million)

6.3.9.2 Market Size, By Distribution Channel, 2019-2026 (USD Million)

6.4 Asia Pacific

6.4.1 Market Size, By Country 2019-2026 (USD Million)

6.4.2 Market Size, By Application, 2019-2026 (USD Million)

6.4.3 Market Size, By Distribution Channel, 2019-2026 (USD Million)

6.4.4 China

6.4.4.1 Market Size, By Application, 2019-2026 (USD Million)

6.4.4.2 Market Size, By Distribution Channel, 2019-2026 (USD Million)

6.4.5 India

6.4.5.1 Market Size, By Application, 2019-2026 (USD Million)

6.4.5.2 Market Size, By Distribution Channel, 2019-2026 (USD Million)

6.4.6 Japan

6.4.6.1 Market Size, By Application, 2019-2026 (USD Million)

6.4.6.2 Market Size, By Distribution Channel, 2019-2026 (USD Million)

6.4.7 Australia

6.4.7.1 Market Size, By Application, 2019-2026 (USD Million)

6.4.7.2 Market size, By Distribution Channel, 2019-2026 (USD Million)

6.4.8 South Korea

6.4.8.1 Market Size, By Application, 2019-2026 (USD Million)

6.4.8.2 Market Size, By Distribution Channel, 2019-2026 (USD Million)

6.5 Latin America

6.5.1 Market Size, By Country 2019-2026 (USD Million)

6.5.2 Market Size, By Application, 2019-2026 (USD Million)

6.5.3 Market Size, By Distribution Channel, 2019-2026 (USD Million)

6.5.4 Brazil

6.5.4.1 Market Size, By Application, 2019-2026 (USD Million)

6.5.4.2 Market Size, By Distribution Channel, 2019-2026 (USD Million)

6.5.5 Mexico

6.5.5.1 Market Size, By Application, 2019-2026 (USD Million)

6.5.5.2 Market Size, By Distribution Channel, 2019-2026 (USD Million)

6.5.6 Argentina

6.5.6.1 Market Size, By Application, 2019-2026 (USD Million)

6.5.6.2 Market Size, By Distribution Channel, 2019-2026 (USD Million)

6.6 MEA

6.6.1 Market Size, By Country 2019-2026 (USD Million)

6.6.2 Market Size, By Application, 2019-2026 (USD Million)

6.6.3 Market Size, By Distribution Channel, 2019-2026 (USD Million)

6.6.4 Saudi Arabia

6.6.4.1 Market Size, By Application, 2019-2026 (USD Million)

6.6.4.2 Market Size, By Distribution Channel, 2019-2026 (USD Million)

6.6.5 UAE

6.6.5.1 Market Size, By Application, 2019-2026 (USD Million)

6.6.5.2 Market Size, By Distribution Channel, 2019-2026 (USD Million)

6.6.6 South Africa

6.6.6.1 Market Size, By Application, 2019-2026 (USD Million)

6.6.6.2 Market Size, By Distribution Channel, 2019-2026 (USD Million)

Chapter 7 Company Landscape

7.1 Competitive Analysis, 2020

7.2 Novo Nordisk A/S

7.2.1 Company Overview

7.2.2 Financial Analysis

7.2.3 Strategic Positioning

7.2.4 Info Graphic Analysis

7.3 Pfizer, Inc.

7.3.1 Company Overview

7.3.2 Financial Analysis

7.3.3 Strategic Positioning

7.3.4 Info Graphic Analysis

7.4 Eli Lilly and Company

7.4.1 Company Overview

7.4.2 Financial Analysis

7.4.3 Strategic Positioning

7.4.4 Info Graphic Analysis

7.5 Sandoz International GmbH (Novartis AG)

7.5.1 Company Overview

7.5.2 Financial Analysis

7.5.3 Strategic Positioning

7.5.4 Info Graphic Analysis

7.6 Merck KGaA

7.6.1 Company Overview

7.6.2 Financial Analysis

7.6.3 Strategic Positioning

7.6.4 Info Graphic Analysis

7.7 Genentech, Inc (Roche)

7.7.1 Company Overview

7.7.2 Financial Analysis

7.7.3 Strategic Positioning

7.7.4 Info Graphic Analysis

7.8 Ferring Pharmaceuticals

7.8.1 Company Overview

7.8.2 Financial Analysis

7.8.3 Strategic Positioning

7.8.4 Info Graphic Analysis

7.9 Teva Pharmaceutical Industries, Ltd.

7.9.1 Company Overview

7.9.2 Financial Analysis

7.9.3 Strategic Positioning

7.9.4 Info Graphic Analysis

7.10 Ipsen

7.10.1 Company Overview

7.10.2 Financial Analysis

7.10.3 Strategic Positioning

7.10.4 Info Graphic Analysis

7.11 Other Companies

7.11.1 Company Overview

7.11.2 Financial Analysis

7.11.3 Strategic Positioning

7.11.4 Info Graphic Analysis

The Global Human Growth Hormone Market has been studied from the year 2019 till 2026. However, the CAGR provided in the report is from the year 2021 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.

The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Human Growth Hormone Market.

The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.

Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.